Cannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of Stock

Cannabis Science Inc (OTCMKTS:CBIS) COO Robert James Kane sold 200,000 shares of the business’s stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $0.13, for a total transaction of $26,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Robert James Kane also recently made the following trade(s):

  • On Friday, December 29th, Robert James Kane sold 200,000 shares of Cannabis Science stock. The stock was sold at an average price of $0.10, for a total transaction of $20,000.00.
  • On Thursday, November 30th, Robert James Kane sold 198,820 shares of Cannabis Science stock. The stock was sold at an average price of $0.06, for a total transaction of $11,929.20.

Cannabis Science Inc (CBIS) traded up $0.01 on Wednesday, hitting $0.13. 103,487,600 shares of the stock traded hands, compared to its average volume of 34,230,000. Cannabis Science Inc has a 12-month low of $0.03 and a 12-month high of $0.14.

ILLEGAL ACTIVITY WARNING: “Cannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of Stock” was originally published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2018/01/03/cannabis-science-inc-cbis-coo-robert-james-kane-sells-200000-shares-of-stock.html.

About Cannabis Science

Cannabis Science, Inc is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Receive News & Ratings for Cannabis Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabis Science and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply